L.SkibickaK
thus, an effective drug targeting this transporter needs to be developed
Most patients experience only mild gastrointestinal side effects, such as nausea or constipation, which often decrease as the body adjusts
Symptoms include too much bloating, feeling full after starting a meal, feeling full long after finishing a meal, vomiting, heartburn, pain in the upper abdomen, poor appetite and too much burping
The drug works mainly by targeting receptors in the digestive system and brain to control appetite, not by directly affecting the gallbladder or bile
These findings underscore the variability in weight management outcomes among patients post-bariatric surgery and highlight the potential role of GLP-1RAs in addressing WR in this population